We are thrilled to announce that Datafoundry has won the Award for “Best use of Machine Learning” in the Idea (Indian Digital Enabler Awards) 2023 – India’s most prestigious award in digital, tech & media community organized by Entrepreneur Magazine. We were chosen amongst 500 total nominations and over 50 in the awarded category.
Saurav Roy, Vice President Engineering and Machine Learning – “Our team has been working tirelessly to push the boundaries of what is possible with machine learning. This award is a recognition of our hard work and dedication to excellence.”
We are honored to be recognized among such a talented group of companies and look forward to continuing to grow and excel in the global AI & Machine Learning space.
We would like to take this opportunity to thank our employees, partners and customers for their continued trust and support. We would not be where we are today without you. Stay tuned for updates on our company’s growth and success as we continue to make waves.
Read the coverage: Indian Digital Enabler Awards 2021 – Awards Winner (entrepreneurindia.com)
About IDEA Awards
The IDEA Awards celebrates organisations across India that enable citizens to transform and enrich their lives through the benefits and opportunities created by digital technologies. The awards are set to recognize the most innovative projects, leadership and digital transformation cases that present a disruptive and innovative approach to customer experience, IT Management and new digital business models. Idea is an effort towards felicitating the diverse tech & digital communities who use technology in creating a better nation and inspiring other similar communities to shine.
Datafoundry is a company with a vision to bring the power of AI/ML to Life Sciences and Healthcare industry for better health outcomes. We are a team of domain experts, data scientists and software developers building best-in-class AI models to deliver insights and process automation to key business processes to enable digital transformation of Life Sciences companies. Our current focus areas include Pharmacovigilance, Literature Research, Labelling, and Real-World Studies.